SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Corpay, Inc. (CPAY) trades at a trailing P/E of 19.8, forward P/E of 12.3. Trailing earnings yield is 5.05%, forward earnings yield 8.12%. PEG 2.60. Graham Number is $145.42.
Criteria proven by this page:
- VALUE (57/100, Partial) — mixed signals — some valuation metrics are favorable while others are stretched.
- Forward P/E 12.3 (down from trailing 19.8) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 2.60 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 5.05% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 8.12% as earnings recover.
- Analyst consensus target $362.13 (+13% upside) — modest upside expected.
Overall SharesGrow Score: 65/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
~
VALUE
57/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
17/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CPAY
Valuation Multiples
P/E (TTM)19.8
Forward P/E12.3
PEG Ratio2.60
Forward PEG0.17
P/B Ratio5.45
P/S Ratio4.71
EV/EBITDA9.6
Per Share Data
EPS (TTM)$15.42
Forward EPS (Est.)$26.03
Book Value / Share$60.95
Revenue / Share$65.27
FCF / Share$18.73
Yields & Fair Value
Earnings Yield5.05%
Forward Earnings Yield8.12%
Dividend Yield0.00%
Graham Number$145.42
SharesGrow IV$1,505.93 (+369.9%)
Analyst Target$362.13 (+13%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
29.0 |
1.07 |
4.25 |
7.15 |
- |
| 2017 |
23.9 |
0.36 |
4.81 |
7.85 |
- |
| 2018 |
20.3 |
1.62 |
4.93 |
6.77 |
- |
| 2019 |
27.8 |
2.08 |
6.70 |
9.38 |
- |
| 2020 |
32.5 |
-1.70 |
6.83 |
9.59 |
- |
| 2021 |
21.9 |
0.99 |
6.41 |
6.48 |
- |
| 2022 |
14.6 |
0.62 |
5.46 |
4.05 |
- |
| 2023 |
21.0 |
3.31 |
6.28 |
5.48 |
- |
| 2024 |
23.7 |
3.74 |
7.62 |
5.99 |
- |
| 2025 |
19.7 |
2.87 |
5.43 |
4.66 |
- |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$4.75 |
$1.83B |
$452.39M |
24.7% |
| 2017 |
$7.91 |
$2.25B |
$740.2M |
32.9% |
| 2018 |
$8.81 |
$2.43B |
$811.48M |
33.3% |
| 2019 |
$9.94 |
$2.65B |
$895.07M |
33.8% |
| 2020 |
$8.12 |
$2.39B |
$704.22M |
29.5% |
| 2021 |
$9.99 |
$2.83B |
$839.5M |
29.6% |
| 2022 |
$12.42 |
$3.43B |
$954.33M |
27.8% |
| 2023 |
$13.20 |
$3.76B |
$981.89M |
26.1% |
| 2024 |
$13.97 |
$3.97B |
$1B |
25.3% |
| 2025 |
$15.03 |
$4.53B |
$1.07B |
23.6% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$26.03 |
$24.13 – $26.82 |
$5.28B |
$5.23B – $5.33B |
12 |
| 2027 |
$29.84 |
$28.36 – $31.14 |
$5.83B |
$5.72B – $5.93B |
11 |
| 2028 |
$34.65 |
$31.49 – $36.44 |
$6.4B |
$6.37B – $6.42B |
3 |
